AlphaTON stock soars 200% after pioneering digital asset oncology initiative
Director Edwin A. Poston of P10, Inc. (NASDAQ:PX), a $1.36 billion market cap company, sold 15,000 shares of Class A Common Stock on August 28, 2025, at a price of $12.57, totaling $188,550. The sale price represents a slight premium to the current trading price of $12.28. According to InvestingPro analysis, P10 shows Fair Value potential and maintains a FAIR overall financial health score.
Following the transaction, Mr. Poston indirectly holds 2,561,507 shares through TrueBridge Colonial Fund, u/a 11/15/2015. He also directly holds 60,502 shares and indirectly holds 521,664 shares through the Edwin A. Poston Revocable Trust. The stock has demonstrated strong momentum with a 24% return over the past year, and analysts maintain a bullish outlook with price targets ranging from $13 to $21. For deeper insights into insider trading patterns and comprehensive analysis, check out the detailed Pro Research Report available on InvestingPro.
In other recent news, P10, Inc. reported its second-quarter earnings for 2025, surpassing market expectations. The company achieved an earnings per share of $0.23, beating the forecasted $0.20. Additionally, P10, Inc. exceeded revenue projections by posting $72.7 million, compared to the anticipated $71.25 million. In a strategic move, P10, Inc. announced plans to dual list its Class A common stock on NYSE Texas Inc., a new electronic equities exchange based in Dallas, while maintaining its primary listing on the New York Stock Exchange. This dual listing is set to be effective on August 15, 2025. The company will continue to trade under the same ticker symbol "PX" on both exchanges. These developments highlight P10, Inc.’s ongoing efforts to expand its market presence and improve its financial performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.